Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP1065481Aexternal-prioritypatent/JPS57126420A/ja
Application filed by IndividualfiledCriticalIndividual
Priority to JP41814490ApriorityCriticalpatent/JPH03246221A/ja
Publication of JPH03246221ApublicationCriticalpatent/JPH03246221A/ja
Publication of JPH0549646B2publicationCriticalpatent/JPH0549646B2/ja
L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
Farmaceutski pripravak prikladan za djelovanje na retikuloendotelni sistem, te za tretiranje mucoviscidoza i sindroma kronične boli koji potječu od degenerativnih lokomotornih bolesti ili prate bolesti tumornog podrijetla, postupak njegovog dobivanja i upotreba